Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus

• Main Authors: R. Garg (Author), L. Latimer (Author), V. Gerdts (Author), A. Potter (Author), S. van Drunen Littel-van den Hurk (Author)
• Formato: Livro
• Publicado em: Taylor & Francis Group, 2017-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Respiratory syncytial virus (RSV) is the most common cause of respiratory tract infections in both children and elderly people. In this study we evaluated the short- and long-term protective efficacy of a single intranasal (IN) immunization with a RSV vaccine formulation consisting of a codon-optimi...